Ben Johnson, Bears and Caleb Williams
Digest more
House, Epstein and Mike Johnson
Digest more
Chief Financial Officer Jill Jaworski said a property tax hike will likely be “part of the package” for 2026 without addressing how to get aldermen to agree to pass it.
Johnson says he wants to put social workers at stops and launch an anti-smoking campaign. A council member who’s pushed for enforcement against smoking says the mayor’s ideas could lack teeth.
Speaker Mike Johnson is leading the chorus of GOP voices accusing Democrats of a double standard in their calls for transparency in Jeffrey Epstein's case.
Explore more
Johnson & Johnson (NYSE:JNJ) is one of the stocks that Jim Cramer shed light on. Cramer was incredibly bullish on the company as he said: “Now, sometimes in this game, you do just get lucky. You’ll come across a surprise quarter that tells you everything you need to know about what can cause a big
6don MSN
The healthcare company's payout currently yields 3.3%, more than double the S&P 500 's ( ^GSPC 0.32%) dividend yield (near a record low at around 1.2%). That high-yielding payout is very healthy, making Johnson & Johnson a very safe way to collect dividend income.
Q2 2025 Earnings Call Transcript July 16, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.77, expectations were $2.68. Operator: Good morning, and welcome to Johnson & Johnson’s Second Quarter 202 Earnings Conference Call.
4h
InvestorsHub on MSNJohnson & Johnson’s Darzalex approved in EU for high-risk smouldering myelomaJohnson & Johnson (NYSE:JNJ) announced Wednesday that the European Commission has granted approval for its Darzalex subcutaneous formulation to be used as a monotherapy for adults diagnosed with high-risk smouldering multiple myeloma.